A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma.

Background: We conducted a multi-center retrospective non-randomized study to clarify roles of 2 and 3 gr/m doses of Cyclophosphamide (Cy) for stem cell mobilization in Multiple Myeloma.

Material And Methods: This study analyzed 169 adult patients who received Cy-based mobilization regimen at doses 2 and 3 gr/m between 2018 and 2024. All patients included in this study were 18 years old and older.